Barclays PLC In Mode Ltd. Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in In Mode Ltd. stock. As of the latest transaction made, Barclays PLC holds 169,630 shares of INMD stock, worth $2.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

169,630

Previous 169,630 -0.0%

Holding current value

$2.9 Million

Previous $2.88 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$15.43 - $19.06 $1.39 Million - $1.72 Million	90,173 Added 113.49%	169,630 $2.88 Million
Q2 2024 Aug 14, 2024	SELL	$17.02 - $21.0 $363,598 - $448,623	-21,363 Reduced 21.19%	79,457 $1.45 Million
Q1 2024 May 15, 2024	SELL	$20.45 - $26.49 $788,408 - $1.02 Million	-38,553 Reduced 27.66%	100,820 $2.18 Million
Q4 2023 Feb 15, 2024	BUY	$19.02 - $30.13 $1.33 Million - $2.11 Million	70,058 Added 101.07%	139,373 $3.1 Million
Q3 2023 Nov 07, 2023	BUY	$30.46 - $46.04 $544,167 - $822,504	17,865 Added 34.72%	69,315 $2.11 Million
Q2 2023 Aug 03, 2023	BUY	$31.57 - $37.73 $1.6 Million - $1.91 Million	50,750 Added 7250.0%	51,450 $1.92 Million
Q1 2023 May 04, 2023	SELL	$29.72 - $41.45 $539,863 - $752,939	-18,165 Reduced 96.29%	700 $22,000
Q4 2022 Feb 13, 2023	SELL	$30.23 - $38.71 $5.33 Million - $6.82 Million	-176,193 Reduced 90.33%	18,865 $672,000
Q3 2022 Nov 03, 2022	SELL	$22.51 - $38.27 $11.7 Million - $19.9 Million	-520,926 Reduced 72.76%	195,058 $5.68 Million
Q2 2022 Aug 12, 2022	BUY	$20.97 - $37.47 $5.12 Million - $9.14 Million	244,019 Added 51.7%	715,984 $16 Million
Q1 2022 May 16, 2022	BUY	$34.38 - $65.77 $16.2 Million - $31 Million	471,965 New	471,965 $17.4 Million

Others Institutions Holding INMD

# of Institutions

294

Shares Held

48.4M

Call Options Held

1.81M

Put Options Held

1.66M

View Full List

About InMode Ltd.

Ticker INMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 83,081,104
Market Cap $1.42B
Description
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedur...

More about INMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account